ZA945625B - Piperazine derivatives - Google Patents

Piperazine derivatives

Info

Publication number
ZA945625B
ZA945625B ZA945625A ZA945625A ZA945625B ZA 945625 B ZA945625 B ZA 945625B ZA 945625 A ZA945625 A ZA 945625A ZA 945625 A ZA945625 A ZA 945625A ZA 945625 B ZA945625 B ZA 945625B
Authority
ZA
South Africa
Prior art keywords
piperazine derivatives
piperazine
derivatives
Prior art date
Application number
ZA945625A
Inventor
Amedeo Leonardi
Gianni Motta
Carlo Riva
Rodolfo Testa
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of ZA945625B publication Critical patent/ZA945625B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/650952Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA945625A 1993-07-30 1994-07-29 Piperazine derivatives ZA945625B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT93MI001717A IT1266582B1 (en) 1993-07-30 1993-07-30 (DI) AZACYLO-HEXANIC AND DIAZACYLO-HEPTANIC DERIVATIVES

Publications (1)

Publication Number Publication Date
ZA945625B true ZA945625B (en) 1995-03-07

Family

ID=11366733

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA945625A ZA945625B (en) 1993-07-30 1994-07-29 Piperazine derivatives

Country Status (14)

Country Link
EP (1) EP0711288A1 (en)
JP (1) JPH09500883A (en)
KR (1) KR960703884A (en)
CN (1) CN1132508A (en)
AU (1) AU680037B2 (en)
CA (1) CA2168443A1 (en)
IL (1) IL110348A0 (en)
IT (1) IT1266582B1 (en)
MX (1) MXPA94005805A (en)
NO (1) NO960371L (en)
NZ (1) NZ271634A (en)
SG (1) SG46281A1 (en)
WO (1) WO1995004049A1 (en)
ZA (1) ZA945625B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5661163A (en) 1995-06-07 1997-08-26 Merck & Co., Inc. Alpha-1a adrenergic receptor antagonists
US5620993A (en) * 1995-06-07 1997-04-15 Merck & Co., Inc. Alpha-1a adrenergic receptor antagonists
US5659033A (en) * 1995-09-13 1997-08-19 Neurogen Corporation N-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands
US5807856A (en) * 1995-11-15 1998-09-15 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonist
ATE225779T1 (en) * 1995-11-17 2002-10-15 Warner Lambert Co SULFONAMIDINE INHIBITORS OF MATRIX METALLOPROTEINASES
US6288091B1 (en) 1995-12-29 2001-09-11 Boehringer Ingelheim Ltd. Antiherpes virus compounds and methods for their preparation and use
PL327582A1 (en) * 1995-12-29 1998-12-21 Boehringer Ingelheim Pharma Derivatives of phenylthiazole exhibiting antiviral properties against herpes virues
ES2188936T3 (en) * 1996-04-05 2003-07-01 Sod Conseils Rech Applic ANTAGONISTS OF THE ALFA-Q-ADRENERGIC RECEIVER.
JP4150435B2 (en) * 1996-04-18 2008-09-17 株式会社資生堂 Alkylene diamine derivatives and anti-ulcer agents, antibacterial agents
US6211215B1 (en) 1996-07-19 2001-04-03 Takeda Chemical Industries, Ltd. Heterocyclic compounds, their production and use
EA001904B1 (en) 1997-05-12 2001-10-22 ОРТО МакНЕЙЛ ФАРМАСЬЮТИКАЛ, ИНК. Arylsubstituted piperazines useful in the treatment of bening prostatic hyperplasia
AU2002300904B2 (en) * 1997-05-12 2004-12-23 Ortho-Mcneil Pharmaceutical, Inc. Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
US6271234B1 (en) 1997-08-01 2001-08-07 Recordati S.A., Chemical And Pharmaceutical Company 1,4-disubstituted piperazines
US6399614B1 (en) 1997-08-01 2002-06-04 Recordati S.A. Chemical And Pharmaceutical Company 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring
IT1293807B1 (en) * 1997-08-01 1999-03-10 Recordati Chem Pharm 1- (N-PHENYLAMINOALKYL) PIPERAZINE DERIVATIVES SUBSTITUTED AT POSITION 2 OF THE PHENYL RING
AU9256498A (en) * 1997-08-01 1999-02-22 Recordati S.A. Chemical And Pharmaceutical Company 1,4-disubstituted piperazines
IT1293804B1 (en) 1997-08-01 1999-03-10 Recordati Chem Pharm DIARYLALKYL PIPERAZINS ACTIVE ON LOW URINARY TRACT
US6218396B1 (en) * 1998-02-20 2001-04-17 Orth-Mcneil Pharmaceutical, Inc. Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
WO2000008001A1 (en) 1998-08-07 2000-02-17 Chiron Corporation Substituted isoxazole as estrogen receptor modulators
US6365591B1 (en) 1999-10-18 2002-04-02 Recordati, S.A., Chemical And Pharmacueticals Company Isoxazolecarboxamide derivatives
IT1314191B1 (en) * 1999-10-18 2002-12-06 Recordati Chem Pharm ISOSSAZOLCARBOSSAMIDIC DERIVATIVES
AR027133A1 (en) * 1999-12-30 2003-03-12 Lundbeck & Co As H DERIVATIVES OF HETEROARILO, ITS PREPARATION AND USE.
SE0004780D0 (en) 2000-12-22 2000-12-22 Jordanian Pharmaceutical Mfg & Novel compunds
JP3940290B2 (en) * 2000-12-22 2007-07-04 ザ・ヨルダニアン・フアーマシユーテイカル・エム・エフ・ジー・アンド・メデイカル・イクイツプメント・カンパニー・リミテツド New compounds
JP2004520347A (en) * 2001-01-15 2004-07-08 グラクソ グループ リミテッド Arylpiperidine and piperazine derivatives as inducers of LDL-receptor expression
US7153858B2 (en) 2003-01-31 2006-12-26 Epix Delaware, Inc. Arylpiperazinyl compounds
WO2008120235A1 (en) * 2007-03-30 2008-10-09 Council Of Scientific & Industrial Research Novel benzophenone hybrids as potential anticancer agents and a process for the preparation thereof
JP4827986B2 (en) 2007-06-08 2011-11-30 マンカインド コーポレ−ション IRE-1α inhibitor
MX2012014273A (en) 2010-06-07 2013-03-22 Novomedix Llc Furanyl compounds and the use thereof.
US9512105B2 (en) 2011-12-09 2016-12-06 Research Triangle Institute 1-substituted 4-arylpiperazine as kappa opioid receptor antagonists
BR102012000187A2 (en) * 2012-01-05 2018-04-10 Univ Rio De Janeiro N-phenylpiperazine derivatives a1a, a1d and 5-ht1a receptor antagonist antagonists in the treatment of benign prostatic hyperplasia, pharmaceutical compositions containing the same
WO2023044364A1 (en) 2021-09-15 2023-03-23 Enko Chem, Inc. Protoporphyrinogen oxidase inhibitors

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2997472A (en) * 1961-08-22 Certificate of correction
FR1543944A (en) * 1967-03-10 1968-10-31 Bruneau & Cie Lab Salicylic acid amide derivatives and their preparation
FR6452M (en) * 1967-03-10 1968-11-12
US3557107A (en) * 1967-05-01 1971-01-19 Shulton Inc Phenylpiperazinylalkyl alkoxy anthranilates
FR1537901A (en) * 1967-07-19 1968-08-30 Bruneau & Cie Lab Amide derivatives of halogeno and nitro benzoic acids and their preparation
FR6924M (en) * 1967-10-18 1969-05-05
US3846430A (en) * 1968-01-12 1974-11-05 Bruneau & Cie Lab 1-(2-methoxy-phenyl)-4-{8 2-(4-fluoro-benzamido)-ethyl{9 -piperazine
NL8005133A (en) * 1980-09-12 1982-04-01 Duphar Int Res PHENYLPIPERAZINE DERIVATIVES WITH ANTIAGRESSIVE ACTION.
US4642291A (en) * 1982-09-01 1987-02-10 Sloan-Kettering Institute For Cancer Research Cell surface antigens of human astrocytoma
JPS5955878A (en) * 1982-09-24 1984-03-31 Chugai Pharmaceut Co Ltd Novel phenylpiperazine derivative
JPS60169467A (en) * 1984-02-10 1985-09-02 Chugai Pharmaceut Co Ltd Novel phenylpiperazine derivative
JP2556722B2 (en) * 1988-02-18 1996-11-20 興和株式会社 Novel sulfonamide compound
US4857644A (en) * 1988-06-09 1989-08-15 American Home Products Corporation Aryl sulfonopiperazines as anti-inflammatory agents
ES2027898A6 (en) * 1991-01-24 1992-06-16 Espanola Prod Quimicos 2-Methoxyphenylpiperazine derivatives.
SG65570A1 (en) * 1992-02-25 1999-06-22 Recordati Chem Pharm Heterobicyclic compounds
SE9201138D0 (en) * 1992-04-09 1992-04-09 Astra Ab NOVEL PHTHALIMIDOALKYL PIPERAZINES

Also Published As

Publication number Publication date
ITMI931717A0 (en) 1993-07-30
NO960371D0 (en) 1996-01-29
ITMI931717A1 (en) 1995-01-30
WO1995004049A1 (en) 1995-02-09
AU7532394A (en) 1995-02-28
IL110348A0 (en) 1994-10-21
KR960703884A (en) 1996-08-31
NZ271634A (en) 1996-09-25
IT1266582B1 (en) 1997-01-09
AU680037B2 (en) 1997-07-17
EP0711288A1 (en) 1996-05-15
NO960371L (en) 1996-03-29
MXPA94005805A (en) 2004-08-20
CN1132508A (en) 1996-10-02
SG46281A1 (en) 1998-02-20
JPH09500883A (en) 1997-01-28
CA2168443A1 (en) 1995-02-09

Similar Documents

Publication Publication Date Title
SG46281A1 (en) Piperazine derivatives
ZA964101B (en) Piperazine derivatives
IL122339A0 (en) Thiohydantoine derivatives
HU9400724D0 (en) 2-thio-substituted carbapeneme derivatives
GB9514901D0 (en) Piperazine derivatives
GB2277517B (en) Piperazine derivatives
ZA945504B (en) Benzocarbocyclic derivatives
GB9509474D0 (en) Piperazine derivatives
ZA932602B (en) Piperazine derivatives
GB2257430B (en) Piperazine derivatives
GB9321688D0 (en) Piperazine derivatives
GB9510600D0 (en) Piperazine derivatives
ZA945589B (en) 2-phenylpyrrole derivatives
HU9402534D0 (en) New naphtoxazine derivatives
ZA947128B (en) Hydroxyethyl-azolyl derivatives
ZA945588B (en) 2-Phenylpyrrole derivatives
GB2274282B (en) Piperazine-and piperidine-isoxazole derivatives
GB9304440D0 (en) 2-acyloxycephem derivatives
GB9308717D0 (en) Piperazine derivatives
GB9324479D0 (en) Piperazine derivatives
HU9301162D0 (en) New piperazine derivatives
IL110645A0 (en) Azoxycyanobenzodioxane derivatives
GB9311613D0 (en) Thienylthiazole derivatives
ZA921587B (en) Piperazine derivatives
GB9321690D0 (en) Piperazine derivatives